respiratory syncytial (RS) virus infection
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)COPD patients 2)COPD patients at stable condition, and COPD patients with exacerbations or patients who were treated for the exacerbations 3)COPD patients or their families who understand the purposes of the study, and sign an agreement form
Exclusion criteria
Exclusion criteria: Patients judged inappropriate by physicians
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) The relation between stage of chronic obstructive pulmonary disease (COPD) and antibody titer of RS virus 2) To confirm the increased antibody titer of RS virus in the exacerbations of COPD | — |
Countries
Japan
Contacts
Tohoku University Graduate School of Medicine Department of Advanced Preventive Medicine for Infectious Disease